Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus Infection

Clinical trial NCT05092074 · UNKNOWN

Trial details

NCT number: NCT05092074
Sponsor: National Taiwan University Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Hepatitis C Virus Infection Treatment Side Effects Adherence, Treatment Effect of Drug

Start date: 2021-10-01
Primary completion: 2022-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.